{"nct_id":"NCT06385080","title":"A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-04-22","start_date_type":"ACTUAL","primary_completion_date":"2026-07-17","primary_completion_date_type":"ESTIMATED","completion_date":"2028-04-17","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["JNJ"]}